Search results for: 'paa1 monitoring software market'

31 Mar 2017  |  North America  |  Market Research

Future of Diabetes Care Paradigms, Forecast to 2022

Innovations to Disrupt Diabetes Wellness, Diagnosis, Monitoring, and Therapy

Infographics

×

Diabetes management is on the verge of being disrupted by innovative technologies such as artificial pancreas, non-invasive glucose monitoring sensors, wearables, apps, and inhalable insulin. This research study captures all the innovative developments across the segments of wellness, diagnosis, monitoring, and therapy of the diabetes care continuu...

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal ...

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectric healing for advanced wound care, non-invasive e...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, and diagnostics industry. The issue includes advanced medical devices such as drug-eluting biologic envelope, autonomous UV-C disinfection robots, arthroscopic surgical robot, four-dimensi...

This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...

Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, with reported cases having doubled since 1990. Today, CVDs account for 1 in 3 deaths worldwide, representing 32% of total global mortality, with heart attacks and ischemic strokes responsible for approximately 85% of these outcomes. The rising burden is stron...

07 Feb 2020  |  Asia Pacific  |  Market Research

Malaysian Diabetes Devices Market, Forecast to 2023

Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

Infographics

×

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...

06 Feb 2020  |  Asia Pacific  |  Market Research

Philippine Diabetes Devices Market, Forecast to 2023

Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

Infographics

×

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...